Literature DB >> 2473417

Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat.

S Shimada1, S Inagaki, Y Kubota, N Ogawa, T Shibasaki, H Takagi.   

Abstract

Coexistence of corticotropin releasing factor and neurotensin and also of substance P and somatostatin was demonstrated in the lateral bed nucleus of the stria terminalis and the central amygdaloid nucleus of the rat, by means of a light microscopic mirror method or immunofluorescent double staining. Using the former technique, a major proportion of corticotropin releasing factor-like immunoreactive cells were found to display neurotensin-like immunoreactivity in the dorsal subdivision of the lateral bed nucleus of the stria terminalis and the lateral subdivision of the central amygdaloid nucleus. On the other hand, the immunofluorescent method showed that a significant number of neurons with both substance P- and somatostatin-like immunoreactivity were located in the ventral subdivision of the lateral bed nucleus of the stria terminalis and the medial subdivision of the central amygdaloid nucleus. Distribution patterns of such co-localized peptides may indicate that there are morphological and biochemical similarities between the dorsal subdivision of the lateral bed nucleus of the stria terminalis and the lateral subdivision of the central amygdaloid nucleus, as well as between the ventral subdivision of the lateral bed nucleus of the stria terminalis and the medial subdivision of the central amygdaloid nucleus. Previous studies have demonstrated that peptide-containing neurons in the lateral bed nucleus of the stria terminalis and central amygdaloid nucleus, such as corticotropin releasing factor-, neurotensin-, substance P- and somatostatin-like immunoreactive cells, project to the lower brainstem. The results of the present study suggest that corticotropin releasing factor/neurotensin and substance P/somatostatin neurons may be part of the lateral bed nucleus of the stria terminalis/central amygdaloid nucleus-lower brainstem pathways.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473417     DOI: 10.1016/0306-4522(89)90259-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

Review 1.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 2.  Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.

Authors:  Nicholas W Gilpin; Marisa Roberto
Journal:  Neurosci Biobehav Rev       Date:  2011-11-11       Impact factor: 8.989

3.  Forebrain GABAergic projections to locus coeruleus in mouse.

Authors:  Eugene L Dimitrov; Yuchio Yanagawa; Ted B Usdin
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

Review 4.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

5.  Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain.

Authors:  S G Matta; J D Valentine; B M Sharp
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

6.  Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model.

Authors:  P N De Francesco; S Valdivia; A Cabral; M Reynaldo; J Raingo; I Sakata; S Osborne-Lawrence; J M Zigman; M Perelló
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

7.  Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.

Authors:  R L Jakab; C Leranth
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

8.  Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.

Authors:  Xiaoli Qi; Lidia Guzhva; Zhihui Yang; Marcelo Febo; Zhiying Shan; Kevin K W Wang; Adriaan W Bruijnzeel
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-22       Impact factor: 4.600

Review 9.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

Review 10.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.